Post-Transplant Glomerulonephritis: Challenges and Solutions

References

• Lim WH, Shingde M, Wong G. Recurrent and de novo glomerulonephritis after kidney transplantation. Front Immunol. 2019;10:1944. doi:10.3389/fimmu.2019.01944
   PubMed Web of Science ®Google Scholar
• Deoliveira M, Sikri H, Yu SMW, He JC. Viral glomerulopathy. Glomerular Dis. 2023;148–154. doi:10.1159/000531434
   PubMedGoogle Scholar
• Posadas Salas MA, Thompson J, Kadian M, Ngo T, Bruner E, Self S. Cytomegalovirus renal infection: rare manifestation of a common post‐transplant viral infection—A case series. Transplant Infect Dis. 2019;21(6):e13169. doi:10.1111/tid.13169
   PubMedGoogle Scholar
• Celik B, Randhawa PS. Glomerular changes in BK virus nephropathy. Hum Pathol. 2004;35(3):367–370. doi:10.1016/j.humpath.2003.09.009
   PubMed Web of Science ®Google Scholar
• Wyld ML, Chadban SJ. Recurrent iga nephropathy after kidney transplantation. Transplantation. 2016;100(9):1827–1832. doi:10.1097/TP.0000000000001093
   PubMed Web of Science ®Google Scholar
• Caster DJ, Lafayette RA. The treatment of primary igA nephropathy: change, change, change. Am J Kidney Dis. 2024;83(2):229–240. doi:10.1053/j.ajkd.2023.08.007
   PubMed Web of Science ®Google Scholar
• Hayashi A, Kawabe M, Yamamoto I, et al. Clinical and pathological significance of mesangial c1q deposition in kidney transplant recipients with recurrent iga nephropathy and patients with native iga nephropathy. Nephron. 2023;147(Suppl. 1):80–88. doi:10.1159/000530916
   PubMedGoogle Scholar
• Cattran DC, Coppo R, Cook HT, et al. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int. 2009;76(5):534–545. doi:10.1038/ki.2009.243
   PubMed Web of Science ®Google Scholar
• Trimarchi H, Barratt J, Cattran DC, et al. Oxford classification of iga nephropathy 2016: an update from the iga nephropathy classification working group. Kidney Int. 2017;91(5):1014–1021. doi:10.1016/j.kint.2017.02.003
   PubMed Web of Science ®Google Scholar
• Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group. KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int. 2021;100(4S):S1–276.
   PubMedGoogle Scholar
• Uffing A, Pérez-Saéz MJ, Jouve T, et al. Recurrence of iga nephropathy after kidney transplantation in adults. Clin J Am Soc Nephrol. 2021;16(8):1247–1255. doi:10.2215/CJN.00910121
   PubMed Web of Science ®Google Scholar
• Vasconcelos A de S, Mazzali M, de Sousa MV. IgA nephropathy and kidney transplantation according to the Oxford classification. Braz J Nephro. 2023;45(3):350–356.
   Google Scholar
• Alachkar N, Delsante M, Greenberg RS, et al. Evaluation of the modified oxford score in recurrent iga nephropathy in north American kidney transplant recipients: the Banff recurrent glomerulonephritis working group report. Transplantation. 2023;107(9):2055–2063. doi:10.1097/TP.0000000000004640
   PubMed Web of Science ®Google Scholar
• De Souza L, Prunster J, Chan D, Chakera A, Lim WH. Recurrent glomerulonephritis after kidney transplantation. Curr Opin Organ Transplant. 2021;26(4):360–380. doi:10.1097/MOT.0000000000000887
   PubMed Web of Science ®Google Scholar
• Floege J, Grone HJ. Recurrent IgA nephropathy in the renal allograft: not a benign condition. Nephrol Dial Transplant. 2013;28(5):1070–1073. doi:10.1093/ndt/gft077
   PubMed Web of Science ®Google Scholar
• Moroni G, Longhi S, Quaglini S, et al. The long-term outcome of renal transplantation of IgA nephropathy and the impact of recurrence on graft survival. Nephrol Dial Transplant. 2013;28(5):1305–1314. doi:10.1093/ndt/gfs472
   PubMed Web of Science ®Google Scholar
• Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant. 2009;9(Suppl 3):S1–157.
   PubMed Web of Science ®Google Scholar
• Gandolfini I, Alibrandi S, Gentile M, et al. Targeted-release budesonide in recurrent IgA nephropathy after kidney transplantation. Kidney Int. 2023;103(5):995–996. doi:10.1016/j.kint.2023.02.012
   PubMed Web of Science ®Google Scholar
• Ronco P, Debiec H. Pathophysiological advances in membranous nephropathy: time for a shift in patient’s care. Lancet. 2015;385(9981):1983–1992. doi:10.1016/S0140-6736(15)60731-0
   PubMed Web of Science ®Google Scholar
• Beckwith H, Kingsbury M, Horsburgh J. Why do people choose nephrology? Identifying positive motivators to aid recruitment and retention. Clin Kidney J. 2018;11(5):599–604. doi:10.1093/ckj/sfy076
   PubMed Web of Science ®Google Scholar
• Beck LH, Bonegio RGB, Lambeau G, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009;361(1):11–21. doi:10.1056/NEJMoa0810457
   PubMed Web of Science ®Google Scholar
• Filippone EJ, Farber JL. Membranous nephropathy in the kidney allograft. Clin Transplant. 2016;30(11):1394–1402. doi:10.1111/ctr.12847
   PubMed Web of Science ®Google Scholar
• Cavanaugh C, Okusa MD. The evolving role of novel biomarkers in glomerular disease: a review. Am J Kidney Dis. 2021;77(1):122–131. doi:10.1053/j.ajkd.2020.06.016
   PubMed Web of Science ®Google Scholar
• Grupper A, Cornell LD, Fervenza FC, Beck LH, Lorenz E, Cosio FG. Recurrent membranous nephropathy after kidney transplantation. Transplantation. 2016;100(12):2710–2716. doi:10.1097/TP.0000000000001056
   PubMed Web of Science ®Google Scholar
• Berchtold L, Letouzé E, Alexander MP, et al. HLA-D and PLA2R1 risk alleles associate with recurrent primary membranous nephropathy in kidney transplant recipients. Kidney Int. 2021;99(3):671–685. doi:10.1016/j.kint.2020.08.007
   PubMed Web of Science ®Google Scholar
• Leon J, Pérez-Sáez MJ, Batal I, et al. Membranous nephropathy posttransplantation: an update of the pathophysiology and management. Transplantation. 2019;103(10):1990–2002. doi:10.1097/TP.0000000000002758
   PubMed Web of Science ®Google Scholar
• Buxeda A, Caravaca-Fontán F, Vigara LA, et al. High exposure to tacrolimus is associated with spontaneous remission of recurrent membranous nephropathy after kidney transplantation. Clin Kidney J. 2023;16(10):1644–1655. doi:10.1093/ckj/sfad077
   PubMed Web of Science ®Google Scholar
• de Sousa MV, Fernandes LGR, de Freitas LLL, Zollner R de L, Mazzali M. De novo membranous nephropathy associated with antibody-mediated rejection in kidney transplant recipients. Transplant Proc. 2022;54(5):1270–1277. doi:10.1016/j.transproceed.2021.11.041
   PubMed Web of Science ®Google Scholar
• El Kossi M, Harmer A, Goodwin J, et al. De novo membranous nephropathy associated with donor‐specific alloantibody. Clin Transplant. 2008;22(1):124–127. doi:10.1111/j.1399-0012.2007.00741.x
   PubMed Web of Science ®Google Scholar
• Patel K, Hirsch J, Beck L, Herlitz L, Radhakrishnan J. De novo membranous nephropathy in renal allograft associated with antibody-mediated rejection and review of the literature. Transplant Proc. 2013;45(9):3424–3428. doi:10.1016/j.transproceed.2013.05.011
   PubMed Web of Science ®Google Scholar
• Honda K, Horita S, Toki D, et al. De novo membranous nephropathy and antibody-mediated rejection in transplanted kidney. Clin Transplant. 2011;25(2):191–200. doi:10.1111/j.1399-0012.2010.01213.x
   PubMed Web of Science ®Google Scholar
• Radhakrishnan Y, Zand L, Sethi S, Fervenza FC. Membranous nephropathy treatment standard. Nephrol Dial Transplant. 2023;9:gfad225.
   Google Scholar
• Salfi G, Casiraghi F, Remuzzi G. Current understanding of the molecular mechanisms of circulating permeability factor in focal segmental glomerulosclerosis. Front Immunol. 2023;14:1247606. doi:10.3389/fimmu.2023.1247606
   PubMed Web of Science ®Google Scholar
• Shabaka A, Tato Ribera A, Fernández-Juárez G. Focal segmental glomerulosclerosis: state-of-the-art and clinical perspective. Nephron. 2020;144(9):413–427. doi:10.1159/000508099
   PubMed Web of Science ®Google Scholar
• Canaud G, Delville M, Legendre C. Recurrence of focal and segmental glomerulosclerosis after transplantation. Transplantation. 2016;100(2):284–287. doi:10.1097/TP.0000000000000902
   PubMed Web of Science ®Google Scholar
• Bai J, Zhang T, Wang Y, et al. Incidence and risk factors for recurrent focal segmental glomerulosclerosis after kidney transplantation: a meta-analysis. Ren Fail. 2023;45(1). doi:10.1080/0886022X.2023.2201341
   Web of Science ®Google Scholar
• Uffing A, Pérez-Sáez MJ, Mazzali M, et al. Recurrence of FSGS after kidney transplantation in adults. Clin J Am Soc Nephrol. 2020;15(2):247–256. doi:10.2215/CJN.08970719
   PubMed Web of Science ®Google Scholar
• Sethi S, Fervenza FC. Membranoproliferative glomerulonephritis — a new look at an old entity. N Engl J Med. 2012;366(12):1119–1131. doi:10.1056/NEJMra1108178
   PubMed Web of Science ®Google Scholar
• Sprangers B, Kuypers DR. Recurrence of glomerulonephritis after renal transplantation. Transplant Rev. 2013;27(4):126–134.
   Web of Science ®Google Scholar
• de Paula LC, Mazzali M, de Sousa MV. Recurrent membranoproliferative glomerulonephritis after kidney transplantation: risk factors and impact on graft survival. Ann Transp. 2023;7(28):e940502.
   Google Scholar
• Caravaca-Fontán F, Polanco N, Villacorta B, et al. Recurrence of immune complex and complement-mediated membranoproliferative glomerulonephritis in kidney transplantation. Nephrol Dial Transplant. 2023;38(1):222–235. doi:10.1093/ndt/gfac148
   PubMed Web of Science ®Google Scholar
• Regunathan-Shenk R, Avasare RS, Ahn W, et al. Kidney transplantation in C3 glomerulopathy: a case series. Am J Kidney Dis. 2019;73(3):316–323. doi:10.1053/j.ajkd.2018.09.002
   PubMed Web of Science ®Google Scholar
• Canaud G, Dejucq-Rainsford N, Avettand-Fenoël V, et al. The kidney as a reservoir for HIV-1 after renal transplantation. J Am Soc Nephrol. 2014;25(2):407–419. doi:10.1681/ASN.2013050564
   PubMed Web of Science ®Google Scholar
• Sharma P, Sawtell R, Wang Q, Sise ME. Management of hepatitis c virus and hepatitis b virus infection in the setting of kidney disease. Adv Kidney Dis Health. 2023;30(4):343–355. doi:10.1053/j.akdh.2023.04.003
   PubMedGoogle Scholar
• Huskey J, Wiseman AC. Chronic viral hepatitis in kidney transplantation. Nat Rev Nephrol. 2011;7(3):156–165. doi:10.1038/nrneph.2010.192
   PubMed Web of Science ®Google Scholar
• Requião-Moura LR, de S-FTV, Viana LA, et al. High mortality among kidney transplant recipients diagnosed with coronavirus disease 2019: results from the Brazilian multicenter cohort study. PLoS One. 2021;16(7):e0254822. doi:10.1371/journal.pone.0254822
   PubMed Web of Science ®Google Scholar
• Klomjit N, Zand L, Cornell LD, Alexander MP. COVID-19 and glomerular diseases. Kidney Int Rep. 2023;8(6):1137–1150. doi:10.1016/j.ekir.2023.03.016
   PubMed Web of Science ®Google Scholar
• Griffiths P, Reeves M. Pathogenesis of human cytomegalovirus in the immunocompromised host. Nat Rev Microbiol. 2021;19(12):759–773. doi:10.1038/s41579-021-00582-z
   PubMed Web of Science ®Google Scholar
• Kant S, Dasgupta A, Bagnasco S, Brennan DC. BK virus nephropathy in kidney transplantation: a state-of-the-art Review. Viruses. 2022;14(8):1616. doi:10.3390/v14081616
   PubMed Web of Science ®Google Scholar